Compare HGBL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HGBL | IXHL |
|---|---|---|
| Founded | 1937 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 37.0M |
| IPO Year | 1998 | 2024 |
| Metric | HGBL | IXHL |
|---|---|---|
| Price | $1.24 | $4.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.85 | N/A |
| AVG Volume (30 Days) | 92.0K | ★ 295.6K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $20,129,000.00 | $12,000.00 |
| Revenue This Year | $11.92 | N/A |
| Revenue Next Year | $13.52 | N/A |
| P/E Ratio | $61.00 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $0.16 |
| 52 Week High | $2.32 | $6.39 |
| Indicator | HGBL | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 60.12 |
| Support Level | $1.20 | $2.68 |
| Resistance Level | $1.45 | $4.22 |
| Average True Range (ATR) | 0.04 | 0.33 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 25.06 | 81.82 |
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It operates in four segments. The Auction and Liquidation segment, which operates as a full-service auction, appraisal, and asset advisory firm, includes the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment. The Refurbishment & Resale segment acquires, refurbishes, and supplies specialized laboratory equipment. Brokerage segment, through NLEX, brokers charged-off receivables in the U.S. and Canada on behalf of financial institutions. The Specialty Lending segment, which provides specialty financing solutions to investors in charged-off and nonperforming asset portfolios.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.